vs
Digimarc CORP（DMRC）与LENZ Therapeutics, Inc.（LENZ）财务数据对比。点击上方公司名可切换其他公司
LENZ Therapeutics, Inc.的季度营收约是Digimarc CORP的1.4倍（$12.5M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -133.6%，领先86.4%），Digimarc CORP自由现金流更多（$895.0K vs $-9.0M）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
LENZ Therapeutics是一家处于临床阶段的生物制药企业，专注于创新眼科疗法的研发，其核心候选产品针对年龄增长引发的老花眼近视力丧失问题，致力于为全球眼科领域未被满足的医疗需求提供解决方案。
DMRC vs LENZ — 直观对比
营收规模更大
LENZ
是对方的1.4倍
$8.9M
净利率更高
DMRC
高出86.4%
-133.6%
自由现金流更多
DMRC
多$9.9M
$-9.0M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $12.5M |
| 净利润 | $-4.2M | $-16.7M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -151.1% |
| 净利率 | -47.2% | -133.6% |
| 营收同比 | 2.9% | — |
| 净利润同比 | 51.4% | -63.5% |
| 每股收益（稀释后） | $-0.18 | $-0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCLENZ
| Q4 25 | $8.9M | — | ||
| Q3 25 | $7.6M | $12.5M | ||
| Q2 25 | $8.0M | $5.0M | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $9.4M | $0 | ||
| Q2 24 | $10.4M | $0 | ||
| Q1 24 | $9.9M | — |
净利润DMRCLENZ
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-16.7M | ||
| Q2 25 | $-8.2M | $-14.9M | ||
| Q1 25 | $-11.7M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-10.8M | $-10.2M | ||
| Q2 24 | $-9.3M | $-10.3M | ||
| Q1 24 | $-10.3M | — |
毛利率DMRCLENZ
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCLENZ
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | -151.1% | ||
| Q2 25 | -105.2% | -337.1% | ||
| Q1 25 | -128.9% | — | ||
| Q4 24 | -105.1% | — | ||
| Q3 24 | -120.4% | — | ||
| Q2 24 | -96.2% | — | ||
| Q1 24 | -109.2% | — |
净利率DMRCLENZ
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -133.6% | ||
| Q2 25 | -102.6% | -298.2% | ||
| Q1 25 | -125.2% | — | ||
| Q4 24 | -99.9% | — | ||
| Q3 24 | -113.9% | — | ||
| Q2 24 | -89.3% | — | ||
| Q1 24 | -104.0% | — |
每股收益（稀释后）DMRCLENZ
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-0.59 | ||
| Q2 25 | $-0.38 | $-0.53 | ||
| Q1 25 | $-0.55 | — | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.50 | $-0.38 | ||
| Q2 24 | $-0.43 | $-0.40 | ||
| Q1 24 | $-0.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $25.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $193.9M |
| 总资产 | $53.0M | $210.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCLENZ
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | $25.4M | ||
| Q2 25 | $16.1M | $37.6M | ||
| Q1 25 | $21.6M | — | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $33.7M | $41.0M | ||
| Q2 24 | $41.5M | $84.0M | ||
| Q1 24 | $48.9M | — |
股东权益DMRCLENZ
| Q4 25 | $40.2M | — | ||
| Q3 25 | $41.4M | $193.9M | ||
| Q2 25 | $46.5M | $206.4M | ||
| Q1 25 | $50.0M | — | ||
| Q4 24 | $61.4M | — | ||
| Q3 24 | $70.2M | $215.3M | ||
| Q2 24 | $77.2M | $192.9M | ||
| Q1 24 | $84.5M | — |
总资产DMRCLENZ
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.4M | $210.7M | ||
| Q2 25 | $60.7M | $217.3M | ||
| Q1 25 | $66.5M | — | ||
| Q4 24 | $75.8M | — | ||
| Q3 24 | $85.0M | $224.0M | ||
| Q2 24 | $93.4M | $202.6M | ||
| Q1 24 | $99.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-8.6M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-9.0M |
| 自由现金流率自由现金流/营收 | 10.0% | -72.2% |
| 资本支出强度资本支出/营收 | 1.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-47.5M |
8季度趋势，按日历期对齐
经营现金流DMRCLENZ
| Q4 25 | $991.0K | — | ||
| Q3 25 | $-2.6M | $-8.6M | ||
| Q2 25 | $-4.7M | $-11.5M | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.1M | $-10.6M | ||
| Q2 24 | $-6.8M | $-15.8M | ||
| Q1 24 | $-8.4M | — |
自由现金流DMRCLENZ
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | $-9.0M | ||
| Q2 25 | $-4.9M | $-11.7M | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | $-10.8M | ||
| Q2 24 | $-6.9M | $-15.9M | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCLENZ
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | -72.2% | ||
| Q2 25 | -61.0% | -235.0% | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCLENZ
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | 3.5% | ||
| Q2 25 | 2.5% | 4.8% | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
LENZ
暂无分部数据
